5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid
TL;DR: 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid (CAS 847243-70-3) is a chemical compound with molecular formula C15H11BrN4O4 and molecular weight 390.00 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
5-bromo-2-[(5-cyano-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinyl)diazenyl]benzoic acid
Also Known As: 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid, 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxopyridin-3-ylidene)hydrazinyl]benzoic acid, (E)-5-bromo-2-(2-(5-cyano-1,4-dimethyl-2,6-dioxo-1,6-dihydropyridin-3(2H)-ylidene)hydrazinyl)benzoic acid, 5-bromo-2-[(2E)-2-(5-cyano-1,4-dimethyl-2,6-dioxo-1,6-dihydropyridin-3(2H)-ylidene)hydrazinyl]benzoic acid, 5-bromo-2-[(2E)-2-(5-cyano-1,4-dimethyl-2,6-dioxopyridin-3-ylidene)hydrazinyl]benzoic acid
| Molecular Formula | C15H11BrN4O4 |
|---|---|
| Molecular Weight | 390.00 g/mol |
| LogP | 3.1471 |
| Topological Polar Surface Area | 128.04 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Exact Mass | 389.99637 |
| Heavy Atoms | 24 |
| Complexity | 972.90515 |
Chemical Identifiers
| CAS Number | 847243-70-3 |
|---|---|
| SMILES | CC1=C(C(=O)N(C(=C1C#N)O)C)N=NC2=C(C=C(C=C2)Br)C(=O)O |
Product Overview
5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid (CAS 847243-70-3), with molecular formula C15H11BrN4O4 and molecular weight 390.00 g/mol. IUPAC: 5-bromo-2-[(5-cyano-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinyl)diazenyl]benzoic acid.
Chemical Property Profile of 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid
Property Insights of 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid
The XLogP value of 3.1471 indicates that 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 128.04 Ų falls within the moderate polarity range, balancing permeability and solubility for 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid. Following Lipinski's Rule of Five, 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid has 2 hydrogen bond donor(s) and 6 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid?
The CAS number of 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid is 847243-70-3.
What is the molecular formula of 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid?
The molecular formula of 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid is C15H11BrN4O4.
What is the molecular weight of 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid?
The molecular weight of 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid is 390.00 g/mol.
Where can I buy 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid?
You can request a quote for 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid?
Yes, KEHONG BIO provides custom synthesis services for 5-bromo-2-[2-(5-cyano-1,4-dimethyl-2,6-dioxo-pyridin-3-ylidene)hydrazinyl]benzoic Acid and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.